Early Alzheimer's Diagnosis Through Blood Test... PeopleBio Launches 'AlzOn' Brand

[Asia Economy Reporter Chunhee Lee] PeopleBio, a blood-based early diagnosis company for degenerative brain diseases, has launched the Alzheimer's dementia blood test brand 'AlzOn' and is promoting the importance of early diagnosis of Alzheimer's.

PeopleBio recently released the Alzheimer's dementia blood test brand AlzOn. It is a testing method that assesses the risk of Alzheimer's dementia through a simple blood draw. Previously, it received medical device product approval from the Ministry of Food and Drug Safety in 2018, and at the end of last year, it also obtained new medical technology certification. Since this year, it has been used in commissioned testing institutions and general hospitals.

AlzOn measures the degree of aggregation (oligomerization) of beta-amyloid, the causative substance of Alzheimer's dementia, to evaluate the risk of the disease. It is expected to assist specialists in making comprehensive judgments for early diagnosis.

Most degenerative brain diseases, including Alzheimer's dementia, are usually diagnosed only when symptoms such as cognitive decline or movement abnormalities are detected. Previously, diagnosis was made using cerebrospinal fluid tests and imaging tests such as positron emission tomography (PET). However, these tests have limitations for early diagnosis due to patient pain, accessibility, and high costs.

A PeopleBio official explained, “AlzOn can measure the pathological phenomena of Alzheimer's dementia through a simple blood draw to determine the risk level,” adding, “The advantage of AlzOn is that the examinee can know the risk level in advance, which helps in continuous management.”

PeopleBio is also running TV and radio advertisements for AlzOn with the catchphrase “A new On perspective to see Alzheimer's.”

Kang Sung-min, CEO of PeopleBio, said, “AlzOn is the world's first Alzheimer's dementia blood test, meaning ‘the start (On) of Alzheimer's care,’” and added, “We aim to become a company that opens new possibilities to help protect health and happiness in the aging era.”

This content was produced with the assistance of AI translation services.